Asthma-Beyond Albuterol
- PMID: 41106877
- DOI: 10.1016/j.emc.2025.06.015
Asthma-Beyond Albuterol
Abstract
Asthma is the most common respiratory disorder in children with a continued significant morbidity and mortality rate despite advancements made in the care of these patients. This review looks at the evidence-based literature to provide those treatments which will provide the best possible response from these patients.
Keywords: Albuterol; Asthma; Reactive airway disease; Respiratory distress.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The author is a Key Opinion Leader and member of the speaker’s bureau for Aerogen. The author also presents compensated lectures on pediatric respiratory emergencies for the American College of Emergency Physicians (ACEP), the American Academy of Pediatrics (AAP), and other commercial CME programs. The author does not intend to discuss an unapproved/investigative use of a commercial product/device in his presentation. I do not have any additional financial supports or funded grants at the time of this chapters’ writing.
